肺癌診斷與治療

Lung Cancer Diagnosis and Treatment

劉會平(Hui-Ping Liu)

《腫瘤護理雜誌》 4卷2期 (2004/12) Pp. 25-34

https://doi.org/10.6880/TJON.200412_4(2).03

摘要

近年來世界各國肺癌的發病率持續上升，不管男性或女性患者皆有顯著增加。雖然過去十年各種冶療的進步如化療或化療結合放療，其存活率普遍並不盡理想。各分期總體五年存活率不到15%。目前醫學文獻顯示第一期非小細胞肺癌病人的手術預後最好，其五年存活率約在50-75%之間，第二期則為30-50%，第三期則僅剩5-25%。通常肺癌病人手術後復發多發生在手術後的前一，二年之內最容易見到。一般臨床上遠處轉移的機會又比局部復發的可能性較高。

關鍵字

肺癌 ； 外科手術 ； 化學／放射治療

並列摘要

The incidence of lung cancer has increased rapidly; lung cancer is the most common cause of cancer deaths in both men and women worldwide. Despite advances in treatment, such as combination chemotherapy and chemoradiation, survival rate has improved very little over the past few decades. The 5-year survival rate for all stages is less than 15%. As revealed in the recent published literature, stage I lung cancer has the best result after surgery, with five year survival rate around 50-75%, followed by 30-50% in stage Ⅱ and 5-25% left in stage Ⅲ lung cancer. The most common recurrent period was within 2 years after surgical resection. Clinically, distant metastasis happens more frequently than the local recurrence.

並列關鍵字

lung cancer ； surgery ； chemoradiotherapy